World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   6492 records for 1208 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusProspective RegistrationMain ID Public TitleDate of Registration
RecruitingYesNCT02980107
Presenting Summary Information From Cochrane Systematic Reviews: Protocol for Research of Infographics Presentation vs. Plain Language Summary
25/11/2016
Not recruitingYesNCT02973295
Silymarin in NAFLD
04/11/2016
RecruitingNoNCT02951650
Long Term Observational Study of a Vagal Nerve Stimulation Device in Crohn's Disease
29/10/2016
Not RecruitingNoISRCTN16181999
Pilot study of carbohydrate sulfotransferase 7 diagnostic utility in non-small cell lung carcinoma
17/10/2016
RecruitingNoNCT02979678
European Organisation of Research and Treatment (EORTC) Quality of Life Questionnaire (QLQ) Breast Cancer Module Update
13/10/2016
RecruitingYesNCT02918656
Presenting Summary Information From Cochrane Systematic Reviews
27/09/2016
Not RecruitingYesCTRI/2016/09/007304
A clinical investigational study to check effects of GS-5745 (study molecule) in patients with Active Ulcerative Colitis
23-09-2016
Not RecruitingNoISRCTN15203878
Preservation C-peptide in type 1 diabetes mellitus
15/09/2016
Not recruitingYesNCT02917499
Efficacy and Safety of TMS and Deep TMS Treatment for Psychiatric and Neurological Disorders
14/09/2016
AuthorisedYesEUCTR2015-004454-17-HU
A Clinical trial to compare Acalabrutinib (ACP-196) versus investigator's choice standard treatment with Bendamustine/Rituximab or Idelalisib/Rituximab alone in patients with with Relapsed or Refractory Chronic Lymphocytic Leukemia 25/08/2016
     
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history